Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation

[1] Bajer L(2017)Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis World J Gastroenterol 23 4548-4558

[2] Kverka M(2016)Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort study Aliment Pharmacol Ther 43 1090-1102

[3] Kostovcik M(2019)Administration of Front Microbiol 10 2259-7770

[4] Macinga P(2017) ameliorates dextran sulfate sodium-induced ulcerative colitis in mice Front Microbiol 8 1765-24

[5] Dvorak J(2007)Next-generation beneficial microbes: the case of Appl Environ Microbiol 73 7767-1103

[6] Stehlikova Z(2019)Intestinal integrity and Ter Arkh 91 17-1648

[7] Brezina J(2019), a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly Nat Med 25 1096-1476

[8] Wohl P(2008)Markers of dysbiosis in patients with ulcerative colitis and Crohn’s disease Appl Environ Microbiol 74 1646-880

[9] Spicak J(2004)Supplementation with Int J Syst Evol Microbiol 54 1469-155

[10] Drastich P(2019) in overweight and obese human volunteers: a proof-of-concept exploratory study Drug Saf 42 869-901

[1] Bajer L(2017)Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis World J Gastroenterol 23 4548-4558

[2] Kverka M(2016)Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort study Aliment Pharmacol Ther 43 1090-1102

[3] Kostovcik M(2019)Administration of Front Microbiol 10 2259-7770

[4] Macinga P(2017) ameliorates dextran sulfate sodium-induced ulcerative colitis in mice Front Microbiol 8 1765-24

[5] Dvorak J(2007)Next-generation beneficial microbes: the case of Appl Environ Microbiol 73 7767-1103

[6] Stehlikova Z(2019)Intestinal integrity and Ter Arkh 91 17-1648

[7] Brezina J(2019), a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly Nat Med 25 1096-1476

[8] Wohl P(2008)Markers of dysbiosis in patients with ulcerative colitis and Crohn’s disease Appl Environ Microbiol 74 1646-880

[9] Spicak J(2004)Supplementation with Int J Syst Evol Microbiol 54 1469-155

[10] Drastich P(2019) in overweight and obese human volunteers: a proof-of-concept exploratory study Drug Saf 42 869-901